ANXA1 and melanoma: To investigate whether annexin A1-mediated inhibition of antigen specific immune responses against apoptotic cells extends to an anti-tumor response, we employed a model of preventive anti-tumor vaccination with apoptotic S2-mOVA cells and monitored the growth of OVA-transfected B16 melanoma cells (B16-OVA) [36].